IQV — IQVIA HOLDINGS INC.
—
NYSE ·
Health Care ·
Life Sciences Tools & Services ·
CIK 1478242 ·
Last close
$235.02
Market Cap
$38.68B
52W High
$251.36
52W Low
$156.24
ADV30
1,596,780
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 4,368,000,000 | 1,435,000,000 | 569,000,000 | 256,000,000 | 29,881,000,000 | 1,909,000,000 | 23,580,000,000 |
| Mar 2026 | 4,151,000,000 | 1,355,000,000 | 565,000,000 | 274,000,000 | 29,675,000,000 | 1,947,000,000 | 23,326,000,000 |
| Dec 2025 | 4,364,000,000 | 1,436,000,000 | 651,000,000 | 514,000,000 | 29,944,000,000 | 1,980,000,000 | 23,314,000,000 |
| Sep 2025 | 4,100,000,000 | 1,373,000,000 | 573,000,000 | 331,000,000 | 28,727,000,000 | 1,814,000,000 | 22,439,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$2,819,000,000
Investing CF
$-2,231,000,000
Financing CF
$-684,000,000
CapEx
$-635,000,000
Dividends Paid
—
Buybacks
$-1,162,000,000
EPS Diluted TTM
$8.06
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$7,699,000,000
Inventory
—
Receivables
$3,375,000,000
ST Investments
$156,000,000
EBIT TTM
$2,352,000,000
Pretax Income TTM
$1,596,000,000
Interest Exp TTM
$756,000,000
Analysts
20
Yahoo Snapshot (yfinance, live)
Total Revenue
$16,983,000,064
EBITDA
$3,048,000,000
Free Cash Flow
$2,149,750,016
Enterprise Value
$52,989,292,544
Total Cash
$2,080,000,000
Total Debt
$16,254,999,552
Shares Out
164,600,000
Trailing EPS
$8.04
Book Value
$37.49
ROE
22.8%
ROA
5.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 16,310,000,000 | 2,287,000,000 | 1,360,000,000 | 29,944,000,000 | 23,314,000,000 | — | 2,654,000,000 |
| Dec 2024 | 15,405,000,000 | 2,269,000,000 | 1,373,000,000 | 26,899,000,000 | 20,832,000,000 | — | 2,716,000,000 |
| Dec 2023 | 14,984,000,000 | 2,061,000,000 | 1,358,000,000 | 26,681,000,000 | 20,569,000,000 | — | 2,149,000,000 |
| Dec 2022 | 14,410,000,000 | 1,827,000,000 | 1,091,000,000 | 25,337,000,000 | 19,572,000,000 | — | 2,260,000,000 |
TTM Snapshot
Revenues TTM
$14,503,000,000
NetIncome TTM
$1,210,000,000
OpCashFlow TTM
$0
Assets (Latest)
$26,899,000,000
Forward EPS
$14.42
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IDXX | IDEXX LABORATORIES INC /DE | $44.10B | $559.07 | — |
| INCY | INCYTE CORP | $24.23B | $119.52 | — |
| MEDP | Medpace Holdings, Inc. | $16.11B | $577.11 | — |
| ICLR | ICON PLC | $12.62B | $163.57 | — |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $11.20B | $232.51 | — |
News headlines (Yahoo Finance, 1h cache)
IQVIA (IQV) Stock Sees Modest Fair Value Lift After Mixed Analyst Target Changes
2026-07-29 23:11 · Yahoo
WM Earnings Beat on Pricing in Q2, Revenues Miss Estimates
2026-07-29 13:58 · Yahoo
Verisk Earnings Surpass Estimates in Q2 on Insurance Growth
2026-07-29 13:55 · Yahoo
IQVIA Holdings (IQV) Earnings Beat Keeps Fair Value In Focus
2026-07-29 09:07 · Yahoo
US Stock Market Today: S&P 500 Futures Slip As Fed Rate Uncertainty Builds
2026-07-29 08:09 · Yahoo
IQVIA (IQV) Shares Skyrocket, What You Need To Know
2026-07-29 03:33 · Yahoo
IQVIA Holdings (IQV) Soars on Revenue Growth Outlook, Strong Q2
2026-07-29 02:55 · Yahoo
IQVIA (IQV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
2026-07-29 01:30 · Yahoo
IQVIA Holdings Inc (IQV) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and AI-Driven ...
2026-07-28 21:00 · Yahoo
US Equity Markets Mixed as Oil Drops, Chip Shares Slide
2026-07-28 20:10 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.